171 related articles for article (PubMed ID: 34802173)
1. Glucagon-like peptide-1 receptor agonist, liraglutide, reduces heroin self-administration and drug-induced reinstatement of heroin-seeking behaviour in rats.
Douton JE; Horvath N; Mills-Huffnagle S; Nyland JE; Hajnal A; Grigson PS
Addict Biol; 2022 Mar; 27(2):e13117. PubMed ID: 34802173
[TBL] [Abstract][Full Text] [Related]
2. Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats.
Evans B; Stoltzfus B; Acharya N; Nyland JE; Arnold AC; Freet CS; Bunce SC; Grigson PS
Brain Res Bull; 2022 Oct; 189():163-173. PubMed ID: 36038016
[TBL] [Abstract][Full Text] [Related]
3. Acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, reduces cue- and drug-induced fentanyl seeking in rats.
Urbanik LA; Acharya NK; Grigson PS
Brain Res Bull; 2022 Oct; 189():155-162. PubMed ID: 36031011
[TBL] [Abstract][Full Text] [Related]
4. Acute glucagon-like peptide-1 receptor agonist liraglutide prevents cue-, stress-, and drug-induced heroin-seeking in rats.
Douton JE; Acharya NK; Stoltzfus B; Sun D; Grigson PS; Nyland JE
Behav Pharmacol; 2022 Aug; 33(5):364-378. PubMed ID: 35695511
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats.
Douton JE; Augusto C; Stoltzfus B; Carkaci-Salli N; Vrana KE; Grigson PS
Behav Pharmacol; 2021 Jun; 32(4):265-277. PubMed ID: 33229892
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide attenuates nicotine self-administration as well as nicotine seeking and hyperphagia during withdrawal in male and female rats.
Herman RJ; Hayes MR; Audrain-McGovern J; Ashare RL; Schmidt HD
Psychopharmacology (Berl); 2023 Jun; 240(6):1373-1386. PubMed ID: 37129617
[TBL] [Abstract][Full Text] [Related]
7. A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats.
Zhang Y; Rahematpura S; Ragnini KH; Moreno A; Stecyk KS; Kahng MW; Milliken BT; Hayes MR; Doyle RP; Schmidt HD
Neuropharmacology; 2021 Jul; 192():108599. PubMed ID: 33965397
[TBL] [Abstract][Full Text] [Related]
8. Effects of training and withdrawal periods on heroin seeking induced by conditioned cue in an animal of model of relapse.
Zhou W; Zhang F; Liu H; Tang S; Lai M; Zhu H; Kalivas PW
Psychopharmacology (Berl); 2009 May; 203(4):677-84. PubMed ID: 19043694
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of the α7 nicotinic receptor antagonist methyllycaconitine in different rat models of heroin reinstatement.
Palandri J; Smith SL; Heal DJ; Wonnacott S; Bailey CP
J Psychopharmacol; 2021 Oct; 35(10):1204-1215. PubMed ID: 33691518
[TBL] [Abstract][Full Text] [Related]
10. Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues.
Zhou W; Liu H; Zhang F; Tang S; Zhu H; Lai M; Kalivas PW
Neuroscience; 2007 Feb; 144(4):1209-18. PubMed ID: 17184925
[TBL] [Abstract][Full Text] [Related]
11. Sleep is increased by liraglutide, a glucagon-like peptide-1 receptor agonist, in rats.
Fang J; Miller P; Grigson PS
Brain Res Bull; 2023 Jan; 192():142-155. PubMed ID: 36410565
[TBL] [Abstract][Full Text] [Related]
12. Greater avoidance of a heroin-paired taste cue is associated with greater escalation of heroin self-administration in rats.
Imperio CG; Grigson PS
Behav Neurosci; 2015 Aug; 129(4):380-8. PubMed ID: 26214212
[TBL] [Abstract][Full Text] [Related]
13. Low dose risperidone attenuates cue-induced but not heroin-induced reinstatement of heroin seeking in an animal model of relapse.
Lai M; Chen W; Zhu H; Zhou X; Liu H; Zhang F; Zhou W
Int J Neuropsychopharmacol; 2013 Aug; 16(7):1569-75. PubMed ID: 23331426
[TBL] [Abstract][Full Text] [Related]
14. Chemogenetic modulation of accumbens direct or indirect pathways bidirectionally alters reinstatement of heroin-seeking in high- but not low-risk rats.
O'Neal TJ; Nooney MN; Thien K; Ferguson SM
Neuropsychopharmacology; 2020 Jul; 45(8):1251-1262. PubMed ID: 31747681
[TBL] [Abstract][Full Text] [Related]
15. The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking.
Bossert JM; Busch RF; Gray SM
Neuroreport; 2005 Jun; 16(9):1013-6. PubMed ID: 15931079
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala.
Alvarez-Jaimes L; Polis I; Parsons LH
Neuropsychopharmacology; 2008 Sep; 33(10):2483-93. PubMed ID: 18059440
[TBL] [Abstract][Full Text] [Related]
17. Cognitive Enhancer Donepezil Attenuates Heroin-Seeking Behavior Induced by Cues in Rats.
Mei D; Wang F; Yuan B; Lai M; Zhou Y; Cui W; Liu H; Zhou W
J Integr Neurosci; 2023 May; 22(3):76. PubMed ID: 37258429
[TBL] [Abstract][Full Text] [Related]
18. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis.
Citraro R; Iannone M; Leo A; De Caro C; Nesci V; Tallarico M; Abdalla K; Palma E; Arturi F; De Sarro G; Constanti A; Russo E
Brain Res Bull; 2019 Nov; 153():133-142. PubMed ID: 31470253
[TBL] [Abstract][Full Text] [Related]
20. Early avoidance of a heroin-paired taste-cue and subsequent addiction-like behavior in rats.
Jenney CB; Petko J; Ebersole B; Njatcha CV; Uzamere TO; Alexander DN; Grigson PS; Levenson R
Brain Res Bull; 2016 May; 123():61-70. PubMed ID: 26494018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
